Laddar...
Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment
BACKGROUND: Eculizumab is approved for atypical hemolytic uremic syndrome (aHUS). Guidelines discuss the importance of prompt treatment. We report a post hoc analysis investigating the effect of baseline factors, including patient characteristics and time from the latest aHUS manifestation to eculiz...
Sparad:
| I publikationen: | J Nephrol |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5316393/ https://ncbi.nlm.nih.gov/pubmed/26995002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-016-0288-3 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|